The efficacy of testosterone or estradiol therapy without a GnRH agonist or progestin to suppress endogenous gonadal activity in transgender patients
2018 ◽
Vol 110
(4)
◽
pp. e21
I.I. Stewart
◽
L.V. Spratt
◽
W. Craig
◽
J.S. Olshan
◽
D.I. Spratt
2008 ◽
Vol 41
(15)
◽
pp. 27
JW Hellinger
◽
G Bauerschmitz
◽
G Emons
◽
C Gründker
2017 ◽
Vol 77
(12)
◽
pp. 1221-1222
C Gründker
◽
AR Günthert
◽
M Hellriegel
◽
G Emons
2019 ◽
Vol 98
(6)
◽
pp. 91-97
N.Y. Raygorodskaya
◽
◽
N.V. Bolotova
◽
V.K. Polyakov
◽
N.B. Zakharova
◽
...